Clinical Trials
50 trialsAcquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms
Massachusetts General Hospital
QiNKT-HSCT
University Hospital Pilsen
ENKLA-M
Nantes University Hospital
CALPRO
Assistance Publique - Hôpitaux de Paris
MDS & PRRT
University Health Network, Toronto
Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation
University of Michigan Rogel Cancer Center
THROMBLEUKEMIA
CHU de Reims
REALL CD9
Rennes University Hospital
GATA-2
Institut Claudius Regaud
OPTIFIL
Assistance Publique - Hôpitaux de Paris
MAHATMAt
Assistance Publique Hopitaux De Marseille
A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia
Memorial Sloan Kettering Cancer Center
Mechanisms of Disease R/R in CAR-T for Hematologic Malignancies
Duke University
PIONEER
Gustave Roussy, Cancer Campus, Grand Paris
SCTMICROBIOM
National Cancer Institute, Slovakia
Early Ageing During Therapy in AYA Cancer Patients
University Medical Center Groningen
INCATH
Medtronic - MITG
REDEFINE
University of Zurich
SANGUINE
JaxBio Ltd
Relation Between Venetoclax Plasma Concentration and Remission in Adults with Acute Myeloid Leukemia (PREDICLAX)
University Hospital, Caen
FUTURE
Assistance Publique Hopitaux De Marseille
VISCOTHEM-1
Centre Hospitalier Annecy Genevois
MinimALL
University of Erlangen-Nürnberg Medical School
Cardiotoxicities in Patients Receiving BTKi
Dana-Farber Cancer Institute
BIO-TIMER
University Hospital, Clermont-Ferrand
CPI-613 Given With Metformin in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Wake Forest University Health Sciences
Description of the Immune Deficiency in Patients With Untreated Chronic Lymphocytic Leukemia and Search for Predictive Factors of Infectious Risk
CHU de Reims
Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia
M.D. Anderson Cancer Center
CReSCT
Melbourne Health
Immunophenotyping of Blast Cells and Immune Effector Cells in Peripheral Whole Blood and Bone Marrow Samples From AML and MDS Patients (AML)
Assistance Publique Hopitaux De Marseille
The Association of Microbiota Composition With cGVHD After Allo-HSCT
First Affiliated Hospital of Zhejiang University
PLANET
Centre Leon Berard
Characterization of Methylation Patterns in Cancer and Non-Cancer cfDNA
Nucleix Ltd.
DIMATE
Assistance Publique Hopitaux De Marseille
TTV-CART
Institut Paoli-Calmettes
PK-E3I
University Hospital, Toulouse
OXYLAM
University Hospital, Toulouse
Interest of a Therapeutic Follow-up of the Cytarabine in the Acute Myeloid Leukaemia: Is There Constitutional Biomarkers
Assistance Publique Hopitaux De Marseille
CCR7-CD4-DPL
University Hospital, Lille
LEA-JA
Institut Paoli-Calmettes
Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies
M.D. Anderson Cancer Center
Telomere and Telomerase
University of Kansas Medical Center
Vitro Study of Tigecycline to Treat Chronic Myeloid Leukemia
Nanfang Hospital, Southern Medical University
LAM-PTK7
Institut Paoli-Calmettes
Evaluation of Cytidine Deaminase for Patient Suffering of a Myelodysplastic Syndrom or an AML Treated by Azacytidine
Assistance Publique Hopitaux De Marseille
Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity
PX Biosolutions
A New Dosing Regimen for Posaconazole Prophylaxis in Children Based on Body Surface Area
Universitaire Ziekenhuizen KU Leuven
Natural Killer Cells Functions, Tumoral Escape to Immune System and Regulation of Natural Cytotoxixity Receptors in Haematological Malignancies
Assistance Publique Hopitaux De Marseille
A Multi-Center Phase 2 Study of VEGF Trap as a Single Agent in Acute Myeloid Leukemia
Vanderbilt-Ingram Cancer Center
Leukemia Cell Cultures for Research of New Anti-Cancer Therapies
University Hospital, Strasbourg, France